Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2-/ERBB2-Altered Advanced Biliary Tract Cancers

被引:0
|
作者
Zeme, Emily L. [1 ]
Van Loon, Katherine [1 ,2 ]
Kelley, Robin K. [1 ,2 ]
Gordan, John D. [1 ,2 ]
机构
[1] Univ Calif San Francisco UCSF, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[2] UCSF, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA
关键词
METASTATIC BREAST-CANCER; TRASTUZUMAB; PLACEBO; FOLFOX;
D O I
10.1200/JCO.24.00868
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers
    Nakazawa, K
    Dobashi, Y
    Suzuki, S
    Fujii, H
    Takeda, Y
    Ooi, A
    JOURNAL OF PATHOLOGY, 2005, 206 (03): : 356 - 365
  • [2] Details of human epidermal growth factor receptor 2 status in 454 cases of biliary tract cancer
    Hiraoka, Nobuyoshi
    Nitta, Hiroaki
    Ohba, Akihiro
    Yoshida, Hiroshi
    Morizane, Chigusa
    Okusaka, Takuji
    Nara, Satoshi
    Esaki, Minoru
    Kishi, Yoji
    Shimada, Kazuaki
    HUMAN PATHOLOGY, 2020, 105 : 9 - 19
  • [3] Human epidermal growth factor receptor 2, epidermal growth factor receptor, and c-MET overexpression and survival in biliary tract cancer: A meta-analysis
    Zhou, Wei
    Jiang, Congqing
    Zhan, Nan
    Lv, Xiaoguang
    Fan, Lifang
    Ninu, Maskey
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S28 - S35
  • [4] Epidermal growth factor receptor and c-erbB-2 oncoprotein expression in human female genital tract carcinosarcomas.
    Costa, MJ
    Walls, J
    LABORATORY INVESTIGATION, 1996, 74 (01) : 510 - 510
  • [5] Emerging Landscape of Targeted Therapy of Breast Cancers With Low Human Epidermal Growth Factor Receptor 2 Protein Expression
    Tozbikian, Gary
    Krishnamurthy, Savitri
    Bui, Marilyn M.
    Feldman, Michael
    Hicks, David G.
    Jaffer, Shabnam
    Khoury, Thaer
    Wei, Shi
    Wen, Hannah
    Pohlmann, Paula
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2024, 148 (02) : 242 - 255
  • [6] Resistance to human epidermal growth factor receptor type 2-targeted therapies
    Thery, Jean-Christophe
    Spano, Jean-Philippe
    Azria, David
    Raymond, Eric
    Llorca, Frederique Penault
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (05) : 892 - 901
  • [7] Human epidermal growth factor receptor 2-targeted therapies in breast cancer
    Nahta, Rita
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (07) : 949 - 952
  • [8] Human epidermal growth factor receptor-2 in oesophageal cancers:An observational study
    Hazem Al-Momani
    Rachel Barnes
    Ahmed El-Hadi
    Rachit Shah
    Wyn G Lewis
    Paul Edwards
    World Journal of Gastroenterology, 2012, (44) : 6447 - 6451
  • [9] Human epidermal growth factor receptor-2 in oesophageal cancers: An observational study
    Al-Momani, Hazem
    Barnes, Rachel
    El-Hadi, Ahmed
    Shah, Rachit
    Lewis, Wyn G.
    Edwards, Paul
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (44) : 6447 - 6451
  • [10] Coexpression of Grb7 with epidermal growth factor receptor or Her2/erbB2 in human advanced esophageal carcinoma
    Tanaka, S
    Mori, M
    Akiyoshi, T
    Tanaka, Y
    Mafune, K
    Wands, JR
    Sugimachi, K
    CANCER RESEARCH, 1997, 57 (01) : 28 - 31